Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Forkhead box P3 (FOXP3) is currently thought to be the most specific marker for naturally occurring CD4(+)CD25(+) T regulatory cells (nTregs). In mice, expression of FoxP3 is strictly correlated with regulatory activity, whereas increasing evidence suggests that in humans, activated T effector cells (Teffs) may also express FOXP3. In order to better define the role of FOXP3 in human Teff cells, we investigated the intensity and kinetics of expression in ex vivo Teff cells, suppressed Teff cells and Teff cell lines. We found that all dividing Teff cells expressed FOXP3, but only transiently, and at levels that were significantly lower than those in suppressive nTregs. This temporary expression in Teff cells was insufficient to suppress expression of reported targets of FOXP3 repressor activity, including CD127, IL-2 and IFN-gamma, and was not correlated with induction of a nTreg phenotype. Thus expression of FOXP3 is a normal consequence of CD4(+) T cell activation and, in humans, it can no longer be used as an exclusive marker of nTregs. These data indicate that our current understanding of how FOXP3 contributes to immune tolerance in humans needs to be re-evaluated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Moreover, even within Tregs the intensity of FOXP3 expression can change, with naive or resting populations of Tregs expressing lower levels of FOXP3 than activated Tregs [379, 380].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [380]
The cited source says what the claim attributes to it.
In the citing paper
“Since Tconvs can also upregulate CD25 and FOXP3, and downregulate CD127 [380, 386], it is critical to set gates for all of these markers on resting populations of T cells, typically using blood cells from healthy individuals.”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [380]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Chen, W., Jin, W., Hardegen, N., Lei, K.-J., Li, L., Marinos, N., McGrady, G., & Wahl, S. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030152 · Cited by 4,699
An essential role for Scurfin in CD4+CD25+ T regulatory cells
Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,856
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Liu, W., Putnam, A. L., Xu-yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A., Kapranov, P., Gingeras, T. R., de St. Groth, B. F., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060772 · Cited by 2,606 · cited 2×
“Recently, it was reported that human nTregs can be distinguished from Teff cells on the basis of low CD127 (IL-7Ra) expression ( 26 , 27), possibly due to the capacity of FOXP3 to interact with and repress the CD127 promoter (26).”
BackgroundRegulatory T Cell Lineage Specification by the Forkhead Transcription Factor Foxp3
Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G., & Rudensky, A. Y. (2005) · Immunity · doi:10.1016/j.immuni.2005.01.016 · Cited by 2,279
Seddiki, N., Santner-Nanan, B., Martinson, J., Zaunders, J., Sasson, S., Landay, A., Solomon, M., Selby, W., Alexander, S. I., Nanan, R., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060468 · Cited by 1,512 · cited 1×
“Recently, it was reported that human nTregs can be distinguished from Teff cells on the basis of low CD127 (IL-7Ra) expression (26, 27 ), possibly due to the capacity of FOXP3 to interact with and repress the CD127 promoter (26).”
BackgroundTNF/TNFR FAMILY MEMBERS IN COSTIMULATION OF T CELL RESPONSES
Watts, T. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115839 · Cited by 1,353
Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells
R.Walker, M., Kasprowicz, D. J., Gersuk, V. H., Bènard, A., Van Landeghen, M., Buckner, J. H., & Ziegler, S. F. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19441 · Cited by 1,245
FOXP3 Controls Regulatory T Cell Function through Cooperation with NFAT
Wu, Y., Borde, M., Heissmeyer, V., Feuerer, M., Lapan, A. D., Stroud, J. C., Bates, D. L., Guo, L., Han, A., Ziegler, S. F., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.042 · Cited by 1,189
Cited by
Items 601–700 of 875
CD90+ Human Dermal Stromal Cells Are Potent Inducers of FoxP3+ Regulatory T Cells
Pfisterer, K., Lipnik, K., Hofer, E., & Elbe‐Bürger, A. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.309 · Cited by 14
“, 2003) and are mostly negative for CD127 (Liu et al., 2006; Allan et al., 2007; Kmieciak et al., 2009).”
BackgroundImmunophenotyping of Human Regulatory T Cells
Staats, J. S. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9650-6_9 · Cited by 13
Snodgrass, R. G., Jiang, X., Stephensen, C. B., & Laugero, K. D. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00357-5 · Cited by 13
“While in mice FoxP3 is an almost exclusive marker of Tregs [46], human FoxP3 + T cells are more heterogenous and include naïve and effector Tregs as well as non-Tregs [21, 47, 48].”
BackgroundKommoju, V., Mariaselvam, C. M., Bulusu, S. N., Kavadichanda, C. G., Narasimhan, P. B., Thabah, M. M., & Negi, V. S. (2023) · Immunologic Research · doi:10.1007/s12026-023-09444-7 · Cited by 12
“Classically, Tregs are defined as either CD4 + CD25 + or CD4 + CD25 + FOXP3 + , but it has been shown that conventional T cells (Tconv) also express a low level of FOXP3 upon TCR stimulation [9].”
Wang, H., Huang, M., Zhu, M., Su, C., Zhang, Y., Chen, H., Jiang, Y., Wang, H., Guo, Q., & Zhang, S. (2024) · Chinese Medicine · doi:10.1186/s13020-024-00904-2 · Cited by 14
“In 1970, Treg was discovered as a member of immunosuppressive cells in TME, forkhead box protein P3 (Foxp3) is the most specific marker of naturally CD4 + CD25 + Tregs (nTregs) [10, 11].”
BackgroundLi, S., Roberts, S. K., Plebanski, M., Gouillou, M., Spelman, T. D., Latour, P., Jackson, D. C., Brown, L. E., Sparrow, R. L., Prince, H. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039368 · Cited by 13
“We cannot exclude the possibility that some FOXP3 cells, especially during the early time points following the initial infusion, may be in vivo activated conventional T cells, as although FOXP3 is the best marker available for Treg it is less specific in humans compared with mice [11,18].”
Efficient expansion of cryopreserved CD4+CD25+CD127lo/− cells in Type 1 diabetes
Rydén, A., & Faresjö, M. (2011) · Results in Immunology · doi:10.1016/j.rinim.2011.08.001 · Cited by 12
Michelozzi, I. M., Gómez‐Castañeda, E., Pohle, R. V. C., Rodriguez, F. C., Sufi, J., Puigdevall, P., Subramaniyam, M., Kirtsios, E., Eddaoudi, A., Wu, S. W., et al. (2020) · Blood · doi:10.1182/blood-2020-141249 · Cited by 14
Satou, A., Asano, N., Kato, S. X., Katsuya, H., Ishitsuka, K., Elsayed, A. A., & Nakamura, S. (2015) · Histopathology · doi:10.1111/his.12885 · Cited by 15
Krustrup, D., Iversen, M., Martinussen, T., Schultz, H. H. L., & Andersen, C. B. (2014) · Clinical Transplantation · doi:10.1111/ctr.12502 · Cited by 12
“This protein is an intracellular transcription factor essential to the generation and function of Tregs (13, 14), and it is furthermore expressed by activated effector T cells but only transiently and to a significantly lower degree (15).”
BackgroundHu, D., Liu, X., Zeng, W., Weiner, H. L., & Ritz, J. (2011) · European Journal of Immunology · doi:10.1002/eji.201141618 · Cited by 12
Chissumba, R. M., Silva-Barbosa, S. D., Augusto, Â. D. R., Maueia, C., Mabunda, N. J., Gudo, E. S., Bhatt, N., Jani, I. V., & Savino, W. (2015) · BMC Immunology · doi:10.1186/s12865-015-0116-x · Cited by 12
“It has been described that the suppressive function of Treg is associated with the density of Foxp3 expression [18–20].”
BackgroundRegulatory T Cells in the Human Immune System
Kim, Y. M. (2010) · Korean Journal of Otorhinolaryngology - Head and Neck Surgery · doi:10.3342/kjorl-hns.2010.53.12.737 · Cited by 12
RetractedSuwandi, J. S., Laban, S., Vass, K., Joosten, A. M., van Unen, V., Lelieveldt, B. P. F., Höllt, T., Zwaginga, J. J., Nikolić, T., & Roep, B. O. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102361 · Cited by 13
Witzleben, A. V., Fehn, A., Grages, A., Ezić, J., Jeske, S. S., Puntigam, L. K., Brunner, C., Kraus, J. M., Kestler, H. A., Doescher, J., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.33446 · Cited by 17
“These markers can be found on other cells (activated effector T cells) or used to detect a heterogeneous group of Tregs including both highly and minimally suppressing cells, respectively.(40) Of note, a combination of different markers would have been a good approach for detecting Tregs properly.”
BackgroundHuang, Z., Li, W., & Su, W. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-6407-9_11 · Cited by 14
Perspectives on Regulatory T Cell Therapies
Probst‐Kepper, M., ger, A. K. O., Garritsen, H., & Buer, J. (2009) · Transfusion Medicine and Hemotherapy · doi:10.1159/000235929 · Cited by 12
Sato, Y., Osada, E., & Manome, Y. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e22911 · Cited by 13
“Another functional difference is that activation-induced FOXP3 expression in T cells has been observed in humans, but not in mice [32].”
BackgroundBlinova, V. G., Gladilina, Y. A., Abramova, A. A., Eliseeva, D. D., Vtorushina, V. V., Shishparenok, A. N., & Zhdanov, D. D. (2023) · Cells · doi:10.3390/cells13010077 · Cited by 14
“Although the expression of FoxP3 is considered the definitive marker of Tregs, several studies have suggested that it can also be expressed in human activated nonregulatory CD4 + T cells [84–86].”
BackgroundHTLV-1 induces an inflammatory CD4+CD8+ T cell population in HTLV-1–associated myelopathy
Maher, A. K., Aristodemou, A., Giang, N., Tanaka, Y., Bangham, C. R. M., Taylor, G. P., & Dominguez‐Villar, M. (2024) · JCI Insight · doi:10.1172/jci.insight.173738 · Cited by 15
Regulatory T Cells in Tumor Microenvironment: Therapeutic Approaches and Clinical Implications
Sureka, N., & Zaheer, S. (2025) · Cell Biology International · doi:10.1002/cbin.70031 · Cited by 13
“CD127, the IL ‐ 7 receptor alpha chain, is typically downregulated in Tregs, serving as a negative marker to distinguish them from effector cells, though this distinction is not absolute (Aerts et al. 2008; Allan et al. 2007).”
Foxp3 positive regulatory T cells: a functional regulation by the E3 ubiquitin ligase Itch
Su, J., & Liu, Y. (2010) · Seminars in Immunopathology · doi:10.1007/s00281-009-0192-1 · Cited by 12
“In addition, in most cases, TGF-β-induced Foxp3+ T cells did not exhibit suppressive function [56–59].”
BackgroundLonie, J. M., Brosda, S., Bonazzi, V., Aoude, L. G., Patel, K., Brown, I., Sharma, S., Lampe, G., Addala, V., Koufariotis, L. T., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1220129 · Cited by 14
“This may re fl ect the homeostatic role of Tregs which accompany effector T cells in the setting of an active anti-tumour immune response (12), however could also be due to FoxP3 expression as a result of T cell activation (42, 43).”
BackgroundFinney, O. C., Lawrence, E., Gray, A. P., Njie, M., Riley, E. M., & Walther, M. R. (2012) · European Journal of Immunology · doi:10.1002/eji.201142164 · Cited by 11
Phenotypically non‐suppressive cells predominate among FoxP3‐positive cells in oral lichen planus
Schreurs, O., Karatsaidis, A., & Schenck, K. (2016) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12447 · Cited by 11
Stabilizing Human Regulatory T Cells for Tolerance Inducing Immunotherapy
He, X., Koenen, H. J. P. M., Slaats, J., & Joosten, I. (2017) · Immunotherapy · doi:10.2217/imt-2017-0017 · Cited by 13
Paul, M., Dayal, D., Bhansali, A. K., Dhaliwal, L., & Sachdeva, N. K. (2018) · Cytotherapy · doi:10.1016/j.jcyt.2018.09.004 · Cited by 12
Majowicz, A., van der Marel, S., Velde, A. A. T., Meijer, S. L., Petry, H., van Deventer, S. J. H., & Ferreira, V. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-172 · Cited by 12
“However, all these methods are more or less impeded with their own limitations [16].”
BackgroundMethodUnraveling the identity of FoxP3+ regulatory T cells in Granulomatosis with Polyangiitis patients
Reijnders, T. D. Y., Stegeman, C. A., Huitema, M. G., Rutgers, A., Heeringa, P., & Abdulahad, W. H. (2019) · Scientific Reports · doi:10.1038/s41598-019-44636-y · Cited by 11
Umhoefer, J. M., Arce, M. M., Kasinathan, S., Whalen, S., Dajani, R., Subramanya, S., Goudy, L., Belk, J. A., Zhou, R. W., Pham, M. T. N., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.10.020 · Cited by 17
Pizzarello, C. R., Jackson, C. M., Herman, K. E., Seppo, A., Rebhahn, J. A., Scherzi, T., Berin, M. C., Looney, R. J., Mosmann, T. R., & Järvinen, K. M. (2025) · Allergy · doi:10.1111/all.16489 · Cited by 12
“Although Foxp3 is traditionally thought of as a marker of Tregs, it can also be transiently expressed following recent cellular activation [32].”
Lactic acid improves Treg manufacturing and in vivo function
Tuomela, K., Leong, E. S. Y., Haque, M., Mangat, S., Fung, V. C. W., García, R., Archambault, A., Boardman, D. A., Geltink, R. I. K., Mojibian, M., et al. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101600 · Cited by 13
“Despite this decreased FOXP3 expression level, the proportion FOXP3-expressing cells was increased by LA. FOXP3 is well-recognized to be regulated by activation, 24 but the functional impact of activation-inducible FOXP3 on Tregs is not well understood.”
Self-citationVillaverde, M. S., Combe, K., Duchene, A. G., Wei, M., Glikin, G. C., & Finocchiaro, L. M. E. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.06.021 · Cited by 10
Regulatory T cells and regulation of allergic airway disease.
Martin, H., & Taube, C. (2012) · Europe PMC (PubMed Central) · Cited by 13
Li, W., Wang, J., Long, R., Su, G., Bukhory, D.-K., Dai, J., Jin, N., Huang, S., Jia, P., Li, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094551 · Cited by 11
“Previous studies have demonstrated that agonist antiCD3 and anti-CD28 mAbs could bind with T cells, and then provide first signal and second signal to induce T cell proliferation [42,48].”
BackgroundCD4+T-cell subsets in rheumatoid arthritis
Ponchel, F., Vital, E. M. J., Kingsbury, S. R., & El-Sherbiny, Y. M. (2012) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.11.69 · Cited by 14
Increased frequency of CD4+CD25high CD127low regulatory T cells in patients with multiple sclerosis
Khosravi, M., Majdinasab, N., Amari, A., & Ghadiri, A. (2019) · Gene Reports · doi:10.1016/j.genrep.2019.100456 · Cited by 10
“The obtained frequency by this way will be more than the actual value; because active T cells without regulatory activity up-regulate the FoxP3 expression (Allan et al., 2007; Tran et al., 2007).”
Bendfeldt, H., Benary, M., Scheel, T., Steinbrink, K., Radbruch, A., Herzel, H., & Baumgrass, R. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00264 · Cited by 12
Zhdanov, D. D., Gladilina, Y. A., Blinova, V. G., Abramova, A. A., Shishparenok, A. N., & Eliseeva, D. D. (2024) · Biomedicines · doi:10.3390/biomedicines12051022 · Cited by 11
“Although the FoxP3 transcription factor is studied as the specific definitive marker of Tregs, several works have suggested that it can also be expressed in human activated non-regulatory CD4 + T cells [91–93].”
BackgroundWilliams, K. M., Dotson, A. L., Otto, A. R., Kohlmeier, J. E., & Benedict, S. H. (2011) · Cellular Immunology · doi:10.1016/j.cellimm.2011.08.010 · Cited by 9
Melenhorst, J. J., Scheinberg, P., Lu, J., Ambrozak, D. R., Sosa, E., Zhao, L., Hensel, N. F., Savani, B. N., Douek, D. C., Price, D. A., et al. (2008) · Cytotherapy · doi:10.1080/14653240701853536 · Cited by 10
Mechanisms of Surveillance of Dendritic Cells by Regulatory T Lymphocytes
Dhainaut, M., & Moser, M. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.08.003 · Cited by 12
Perry, N. T., Wasko, K. M., Cheng, J. K. W., Tabbaa, D., Marco, E., Giannoukos, G., Albright, C. F., & Borges, C. M. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.1901275 · Cited by 7
“One explanation for the lagging translation of these important findings from mouse to human is that human CD4-positive effector T cells, referred to in this study as non-Tregs, transiently express FOXP3 following activation, making it difficult to distinguish human Tregs from non-Tregs by FOXP3 protein expression alon…”
BackgroundThe frequency of Treg subsets distinguishes disease activity in ANCA vasculitis
Agosto‐Burgos, C., Wu, E. Y., Iannone, M. A., Hu, Y., Hogan, S. L., Henderson, C. D., Kennedy, K. B., Blazek, L. N., Herrera, C. A., Munson, D., et al. (2022) · Clinical & Translational Immunology · doi:10.1002/cti2.1428 · Cited by 9
“transiently.(31,32) Perhaps, FOXP3D2 CD4 T cells are activated effector T cells that transiently upregulated the expression of FOXP3, which can explain their diminished suppressive capacity and Th17 pro-inflammatory cytokine profile.”
BackgroundStigliani, S., Croce, M., Morandi, F., Scaruffi, P., Rigo, V., Carlini, B., Manzitti, C., Gigliotti, A. R., Tonini, G. P., Pistoia, V., et al. (2015) · BioMed Research International · doi:10.1155/2015/347867 · Cited by 10
Retinoic Acid Generates Regulatory T Cells in Experimental Transplantation
Moore, C., Fuentes, C., Sauma, D., Morales, J., Bono, M. R., Rosemblatt, M. S., & Fierro, J. A. (2011) · Transplantation Proceedings · doi:10.1016/j.transproceed.2011.06.057 · Cited by 9
“In fact, human effector T cells transiently express Foxp3 during their activation process.(7,8) Other features such as the existence of 2 Foxp3 isoforms and dynamic epigenetic mechanisms add further complexity to the system.”
BackgroundNocentini, G., Cari, L., Migliorati, G., & Riccardi, C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809912-4.00016-7 · Cited by 9
Bassler, K. E., Schmidleithner, L., Shakiba, M. H., Elmzzahi, T., Köhne, M., Floess, S., Scholz, R., Ohkura, N., Sadlon, T. J., Klee, K., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1107397 · Cited by 9
“This is in agreement with previous reports describing CD4 T cells in humans which upregulate the expression of FOXP3 without the acquisition of a suppressive capacity (70, 71).”
ResultBeretta‐Piccoli, B. T., Mieli‐Vergani, G., & Vergani, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23947-2.00074-6 · Cited by 11
Kabha, M., Liaks-Bohnick, M., Zagairy, F., Atar, O., Hamed, M., Ziv, M., Danial‐Farran, N., Khayat, M., Ishach, O., Dinur-Schejter, Y., et al. (2025) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2025.07.018 · Cited by 8
Saito, H. (2009) · The Journal of Toxicological Sciences · doi:10.2131/jts.34.sp313 · Cited by 8
Engagement of distinct epitopes on CD 43 induces different co‐stimulatory pathways in human T cells
Modak, M., Majdic, O., Cejka, P., Jutz, S., Puck, A., Gerwien, J. G., Steinberger, P., Zlabinger, G. J., Strobl, H., & Stöckl, J. (2016) · Immunology · doi:10.1111/imm.12642 · Cited by 8
DNA methylation in blood—Potential to provide new insights into cell biology
Macartney-Coxson, D. P., Cameron, A. M., Clapham, J., & Benton, M. C. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241367 · Cited by 8
Salcido-Ochoa, F., Yusof, N., Hue, S. S., Haase, D., Kee, T. Y. S., & Rötzschke, O. (2012) · Journal of Transplantation · doi:10.1155/2012/397952 · Cited by 10
“Another possibility is that the use of Foxp3 expression as a surrogate marker for Treg presence or function could lead to an overestimation of the actual amount of Treg-mediated immunosuppression, as it is well known in humans Foxp3 can be expressed transiently by Teffs during their activation [19].”
BackgroundInfluentialSjåheim, T., Bjørtuft, Ø., Drabløs, P. A., Kongerud, J. S., & Halstensen, T. S. (2013) · Scandinavian Journal of Immunology · doi:10.1111/sji.12035 · Cited by 8
Lehtoviita, A., Rossi, L. H., Kekäläinen, E., Sairanen, H. I., & Arstila, T. P. (2009) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2009.02307.x · Cited by 8
CD4+ CD25+ cells in type 1 diabetic patients with other autoimmune manifestations
Elaziz, D. S. A., Hafez, M., Galal, N. M., Meshaal, S. S., & Elmarsafy, A. M. (2013) · Journal of Advanced Research · doi:10.1016/j.jare.2013.09.004 · Cited by 8
“One explanation may be due to CD4CD25 expression by the activated T effectors cell which can be increased in inflammatory and autoimmune diseases [12].”
T cells stimulatedin vitrohave a suppressive function but do not contain only regulatory T cells
Valencic, E., Piscianz, E., Tommasini, A., & Granzotto, M. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03502.x · Cited by 9
Molecular and temporal control of restimulation-induced cell death (RICD) in T lymphocytes
Lee, K. P., Epstein, B. E., Lake, C. M., & Snow, A. L. (2023) · Frontiers in Cell Death · doi:10.3389/fceld.2023.1281137 · Cited by 7
“Although this short-lived FOXP3 expression is not sufficient to endow Tcons with suppressive function, conflicting reports suggest it may regulate Tcon proliferation and cytokine production (Allan et al., 2007; Wang et al., 2007; Cavatorta et al., 2012; McMurchy et al., 2013).”
Transcriptional fingerprinting of regulatory T cells: ensuring quality in cell therapy applications
Cheng, Z., Wang, L., Honaker, Y., Cincotta, S. A., Page, C. E., Vollhardt, S., Yuan, V., Long, S. A., Xiao, Y., Beilke, J. N., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1602172 · Cited by 8
“D14 Teff, however, had moderate expression of FOXP3, which has been well described as being transiently upregulated in activated Teff cells (35, 36).”
Nam, M. (2025) · Clinical Transplantation and Research · doi:10.4285/ctr.25.0040 · Cited by 10
“Importantly, some studies have shown that activated non-Tregs can transiently express FOXP3 without acquiring suppressive activity [105].”
Park, H., Shin, M. S., Shin, J. J., Kim, H., Kang, B., Par‐Young, J., Ünlü, S., Afinogenova, Y., Catanzaro, J., Young, J. J., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105114 · Cited by 8
“15,16 In contrast, high expression levels of the Th1 cell differentiation transcription factor, T-bet, in metacluster 2 cells support potent effector capacity.”
BackgroundMechanistic and Biomarker Studies to Demonstrate Immune Tolerance in Multiple Sclerosis
Docampo, M. J., Lutterotti, A., Sospedra, M., & Martinꝉ, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.787498 · Cited by 9
PHLPP Signaling in Immune Cells
Lordén, G., Lam, A. J., Levings, M. K., & Newton, A. C. (2022) · Current topics in microbiology and immunology · doi:10.1007/978-3-031-06566-8_5 · Cited by 11
Self-citationPlasticity and Overlap of In Vitro–Induced Regulatory T-Cell Markers in Healthy Humans
Wang, H., Daniel, V., Sadeghi, M., & Opelz, G. (2013) · Transplantation Proceedings · doi:10.1016/j.transproceed.2012.10.060 · Cited by 7
Mohiuddin, I. H., Pillai, V., Baughman, E. J., Greenberg, B. M., Frohman, E. M., Crawford, M. P., Sinha, S., & Karandikar, N. J. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.05.001 · Cited by 9
Dysregulation and therapeutic prospects of regulatory T cells in type 1 diabetes
Khaja, A. S. S., Binsaleh, N. K., Qanash, H., Alshetaiwi, H. S., Ginawi, I., & Saleem, M. (2025) · Acta Diabetologica · doi:10.1007/s00592-025-02478-3 · Cited by 8
“Notably, the phenotypic and intracellular markers traditionally used to define Tregs, such as CD25 (also known as IL2RA, inter - leukin-2 receptor α) and Foxp3, are not exclusive to Tregs and can also be expressed on other activated effector T cells [39, 40 ].”
Characterization of human epithelial resident memory regulatory T cells
Sato, T., Ogawa, Y., Yokoi, K., Nagasaka, Y., Ishikawa, A., Shiokawa, I., Kinoshita, M., Watanabe, R., Shimada, S., Tanaka, A., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.962167 · Cited by 8
“However, given that Foxp3 is a T-cell activation marker (18), it was uncertain whether these cells were “true” Tregs.”
BackgroundLocal T cell infiltrates are predominantly associated with corneal allograft rejection
Sakowska, J., Glasner, P., Dukat-Mazurek, A., Rydz, A., Zieliński, M., Pellowska, I., Biernat, W., Glasner, L., Michalska‐Małecka, K., & Trzonkowski, P. (2023) · Transplant Immunology · doi:10.1016/j.trim.2023.101852 · Cited by 6
Kandulski, A., Wex, T., Kuester, D., Mönkemüller, K. E., Peitz, U., Roessner, A., & Malfertheiner, P. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0746-z · Cited by 6
“Also, other activated (non-regulatory) T cells were recently described to express FOXP3 as well [23, 24].”
BackgroundModulation of the TCR stimulation strength can render human activated CD4+ T cells suppressive
Noel, G. L., Brinster, C., Sémana, G., & Bruniquel, D. (2009) · International Immunology · doi:10.1093/intimm/dxp068 · Cited by 6
IPEX syndrome and human Treg cells
Otsubo, K., Kanegane, H., Kobayashi, I., & Miyawaki, T. (2010) · Japanese Journal of Clinical Immunology · doi:10.2177/jsci.33.196 · Cited by 6
Decreased Helios Expression in Regulatory T Cells in Acute Coronary Syndrome
Jiang, L., Chen, F., Hu, X.-F., Hu, Y., Wang, Y., Zhang, W., Peng, Y., & Cheng, L. (2017) · Disease Markers · doi:10.1155/2017/7909407 · Cited by 6
“Furthermore, some authors have reported that the suppression function of CD4 +CD25hi Tregs was not altered in patients [32], whereas others claim that Foxp3+ Tregs are not able to suppress the inflammatory cytokines [21, 22].”
BackgroundChikileva, I. O., Shubina, I. Z., Baronzio, G., & Kiselevsky, M. V. (2010) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2010.01.021 · Cited by 6
“They observed that under strong activation conditions virtually 100% of effector Th cells expressed FOXP3 and CD25 [13].”
BackgroundResultInfluentialDown-regulation of Helios Expression in Tregs from Patients with Hypertension
Chen, Z.-Y., Chen, F., Wang, Y., Wang, D.-H., Jang, L.-L., & Cheng, L.-X. (2018) · Current Medical Science · doi:10.1007/s11596-018-1846-9 · Cited by 6
The effect of IL-28A on human cord blood CD4+T cells
Arasteh, J., Ebtekar, M., Pourpak, Z., Pourfatollah, A. A., Hassan, Z. M., & Farahmandian, T. (2010) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923970903317445 · Cited by 6
Activation of aryl hydrocarbon receptor prolongs survival of fully mismatched cardiac allografts
Cai, L., Yu, D.-W., Gao, Y., Yang, C., Zhou, H., & Chen, Z. K. (2013) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-013-1097-8 · Cited by 7
Nayyar, A. (2009) · University Library - University of Saskatchewan (University of Saskatchewan) · Cited by 6
Muhammad, F. A., Shareef, A., Jyothi, S. R., Kumar, S., Chauhan, A. S., Gautam, A., Джамшедовна, А. М., Sameer, H. N., Yaseen, A., Athab, Z. H., et al. (2025) · Immunological Investigations · doi:10.1080/08820139.2025.2529970 · Cited by 10
Expanding the diagnostic toolbox for complex genetic immune disorders
Abrams, E. D., Basu, A., Thomas, M. E. Z., Henrickson, S. E., & Abraham, R. S. (2024) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2024.11.022 · Cited by 7
Protschka, M., Placido, D. D., Moore, P. F., Büttner, M., Alber, G., & Eschke, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1400550 · Cited by 9
Laytragoon‐Lewin, N., Jönson, F., Lundgren, J., Rutqvist, L. E., Wikby, A., Löfgren, S., & Lewin, F. (2014) · Medical Oncology · doi:10.1007/s12032-014-0290-3 · Cited by 5
Tsuda, M., Tone, Y., Ogawa, C., Nagaoka, Y., Katsumata, M., Necula, A. S., Howie, D., Masuda, E. S., Waldmann, H., & Tone, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00279 · Cited by 5
Sirolimus Increases T-Cell Abundance in the Sun Exposed Skin of Kidney Transplant Recipients
Burke, M., Nahum, L. C. S., Isbel, N. M., Carroll, R. P., Soyer, H. P., Francis, R. S., Bridge, J. A., Hawley, C. M., Oliver, K., Staatz, C. E., et al. (2017) · Transplantation Direct · doi:10.1097/txd.0000000000000694 · Cited by 5
Černý, V., Novotná, O., Petrásková, P., Hudcová, K., Boráková, K., Prokešová, L., Kolářová, L., & Hrdý, J. (2021) · Biomedicines · doi:10.3390/biomedicines9020170 · Cited by 9
“Nonetheless, it has been shown that FOXP3 expression can transiently be upregulated in activated T cells [83,84].”
BackgroundContext-Dependent Effects Explain Divergent Prognostic Roles of Tregs in Cancer
Amblard, E., & Soumelis, V. (2022) · Cancers · doi:10.3390/cancers14122991 · Cited by 6
Merlo, A. C., Tagliabue, E., Ménard, S., & Balsari, A. (2008) · Immunology Letters · doi:10.1016/j.imlet.2008.01.006 · Cited by 5
Zitvogel, L., Mignot, G., Bonmort, M., Ullrich, E., & Chaput, N. (2008) · médecine/sciences · doi:10.1051/medsci/2008245525 · Cited by 5
Is Foxp3 a good marker for regulatory T cells?
Sayed, D. M., El‐Badawy, O., Eldin, E. N., Bakry, R., Badary, M. S., Abd-Alrahman, M. E., El‐Feky, M. A., & Thabit, A. G. (2014) · PubMed · Cited by 5
Weitz, M., Strahm, B., Meerpohl, J. J., & Bassler, D. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009898.pub2 · Cited by 5
Zhou, Q., Xu, F., Wen, J., Yue, J., Zhang, Y., Du, L., Kou, K., Su, J., Liu, Y., & Liang, X. (2025) · Cancer Medicine · doi:10.1002/cam4.70980 · Cited by 5
“However, previous studies have shown that transient expression of CD25 and FoxP3 can also occur in activated conventional CD4 + T cells without regulatory function [27, 28].”
Schwarz, T., Almanzar, G., Wulfheide, M., Woidich, R., Holzer, M., Christoforou, T., Karle, L., Radtke, D., Brauneiser, F., Haaf, T., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157339 · Cited by 6
“Furthermore, it needs to be considered that FoxP3 is not only a marker for helper T cells with Treg features but is also expressed by activated non-Treg cells, which may significantly contribute to the peripheral T cell pool [42].”
Valentín‐Quiroga, J., Santoveña, A. Z., López‐Collazo, E., & Ferreira, L. M. R. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1601385 · Cited by 5
“1 cells (Figure 2D), an additional line of evidence for CHAR Treg activation speci fi cally by anti-HLA-A2 antibody-producing cells (39).”
Effects of CRISPR-Cas9-mediated FOXP3 knockout on CAR T cell potency
Peter, L., Farrera-Sal, M., Yaman, F. A., Dempewolf, N. H., Picht, S., Schulenberg, S., Kath, J., Hamm, F., Heinrich, F., Wagner, D. L., et al. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101570 · Cited by 5
Peripheral biomarkers for individualizing immunosuppression in transplantation - Regulatory T cells
Schlickeiser, S., & Sawitzki, B. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.02.010 · Cited by 5
Lin, Y., Sakuraba, S., Massilamany, C., Reddy, J., Tanaka, Y., Miyake, S., & Yamamura, T. (2023) · Journal of Autoimmunity · doi:10.1016/j.jaut.2023.103094 · Cited by 4
Forkhead Box Protein P3 in the Immune System
Sato, Y. (2025) · Allergies · doi:10.3390/allergies5010006 · Cited by 4
“In contrast to murine T cells, human T cells express FOXP3 upon TCR stimulation [16,17].”
Activation-dependent mitochondrial translocation of Foxp3 in human hepatocytes
Rojas, J., Terán‐Ángel, G., Barbosa, L., Peterson, D. L., Berrueta, L., & Salmen, S. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.04.008 · Cited by 6
“9 effector T cells or Treg function (11, 23), the next question was whether this upregulation”
BackgroundNew insight into GARP striking role in cancer progression: application for cancer therapy
Lahimchi, M. R., Eslami, M., & Yousefi, B. (2022) · Medical Oncology · doi:10.1007/s12032-022-01881-y · Cited by 3
“It also seems that the expression of GARP is significantly dependent on the T cell receptor (TCR) activation [43, 44].”
BackgroundZhang, L., & Xia, C. (2013) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20130668 · Cited by 4
“Because in humans, FoxP3 is expressed in Tregs with potent suppressor cell activity, as well as in some activated conventional T cells.(13,14)”
Metadata
- Authors
- Allan, S. E., Crome, S. Q., Crellin, N. K., Passerini, L., Steiner, T. S., Bacchetta, R., Roncarolo, M. G., & Levings, M. K.
- Affiliations
- University of British Columbia (CA)
- The San Raffaele Telethon Institute for Gene Therapy (IT)
- Vita-Salute San Raffaele University (IT)
- Venue
- International Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-02-20
- Volume
- 19
- Issue
- 4
- Pages
- 345-354
- ISSN
- 0953-8178 (ISSN-L)
- 1460-2377
- OpenAlex
- W2139019810
- Cited by
- 872
- References
- 39
- Citations by year
- 2026: 13 · 2025: 24 · 2024: 24 · 2023: 21 · 2022: 25 · 2021: 33 · 2020: 22 · 2019: 34 · 2018: 34 · 2017: 36 · 2016: 26 · 2015: 46 · 2014: 62 · 2013: 62 · 2012: 67
- FWCI
- 34.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Immunology (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- Foxp3, CD4+CD25+ T cells, T cell activation, T cell proliferation, cytokine production, CD127, interleukin-2, interferon-gamma, immune tolerance, human T cells
- MeSH terms
- CD69 Antigens, Antibodies, Antigens, Differentiation, Antigens, Differentiation, T-Lymphocyte, Cell Line, Cysteine, Flagellin, Humans, Interferon-gamma, Interleukin-2, Lipoproteins, Lymphocyte Activation, CD4-Positive T-Lymphocytes, Antigens, CD, T-Lymphocyte Subsets, Cytokines, CD3 Complex, Receptors, Nerve Growth Factor, Clonal Anergy, CD28 Antigens, Receptors, Tumor Necrosis Factor, Coculture Techniques, Lectins, C-Type, Cell Proliferation, T-Lymphocytes, Regulatory, Toll-Like Receptors, Forkhead Transcription Factors, Glucocorticoid-Induced TNFR-Related Protein, Interleukin-2 Receptor alpha Subunit, Interleukin-7 Receptor alpha Subunit, CTLA-4 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.